PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy

NCT05246670 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-Induced Peripheral Neuropathy
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Interventions

DRUG: Palmidrol
DRUG: Placebo Administration
OTHER: Quality-of-Life Assessment

Sponsor

Academic and Community Cancer Research United

Collaborators

[object Object]